The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults
ProSauce
Testing the Effect of a Plant-based, Protein-dense Sauce (ProSauce) on Metabolic Availability of Essential Amino Acids and Gut Fullness and Satiety in Older Adults
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this clinical trial is to determine whether meals fortified with plant-based high protein sauce (ProSauce) provide better metabolic availability of essential amino acids compared to meals with standard lower-protein sauce without resulting in excessive gut fullness and satiety. The main questions it aims to answer are: Does meals with high-protein sauce deliver better metabolic availability of amino acid profile? Does this high-protein sauce also not lead to excessive appetite suppression due to its liquid form? Researchers will compare high protein sauce to a commercially available standard low protein sauce. Participants will consume two meals, either protein-fortified or standard low-protein sauce, in a randomised order with at least a one-week washout period between each meal. The investigators will collect venous blood samples over a 6-hour postprandial period to measure plasma essential (and non-essential) amino acid and insulin concentrations. The investigators will also measure appetite-related hormones from venous plasma and assess subjective appetite using a visual analogue scale, taken in parallel with the blood sample time points.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2025
CompletedFirst Posted
Study publicly available on registry
May 11, 2025
CompletedStudy Start
First participant enrolled
July 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedSeptember 23, 2025
September 1, 2025
4 months
April 23, 2025
September 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentrations of essential amino acids
Baseline and postprandial plasma amino acid concentrations will be measured to provides valuable insights into protein digestion and absorption.
Essential amino acid concentrations at time points of baseline, immediately after breakfast (t =0 minute) and t = 20, 40, 60, 90, 120, 180, 240, 300, 360 minutes.
Secondary Outcomes (1)
Concentrations of appetite-related gut hormones
Appetite-related gut hormones will be measured at time points of baseline, immediately after breakfast (t =0 minute) and t = 20, 40, 60, 90, 120, 150, 180, 210, 240 minutes.
Study Arms (2)
ProSauce
EXPERIMENTALstandard sauce
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Aged 60 and over
- Living independently in the community
- Capacity to provide informed consent
- Non-smoking (vaping is considered smoking)
- No known medical conditions that might influence the study outcomes, e.g., heart disease, diabetes mellitus, obesity, disthyroidism and other endocrinopathies and renal failure
- Not taking any medications that might influence the study outcomes e.g., taking anabolic steroids or corticosteroids long term
- No clinically diagnosed eating disorders
- No severe dislike or allergy to any of the study food
- No hospitalisations in the last 6 months
- Not dieting and weight stable for 3 months before the study (\< 3 kg change in weight)
You may not qualify if:
- Age \< 60y
- Smoking
- Food allergies
- Cognitive and mobility issues
- Hospitalisation in the last 6 months
- Known medical conditions that might influence the study outcomes
- Taking medications that influence the study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Exeter
Exeter, Devon, EX44DZ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna Bowtell, Prof
University of Exeter
Central Study Contacts
Joanna Bowtell, Prof
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2025
First Posted
May 11, 2025
Study Start
July 10, 2025
Primary Completion
October 30, 2025
Study Completion
April 30, 2026
Last Updated
September 23, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share